Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
170.80    0.40 (0.23%)
Bid:
171.60
Ask:
171.80
Spread: 0.20 (0.117%)
Market Cap: £1.26b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

New Banking Facilities

1 Oct 2009 07:00

RNS Number : 0050A
Grainger PLC
01 October 2009
 



1 October 2009

Grainger plc ("Grainger" or the "Group")

GRAINGER SIGNS NEW BANKING FACILITIES

WITH EXTENDED MATURITIES

Grainger signs £615 million of Forward Start Facilities, significantly strengthening the Group's liquidity profile until December 2012

In its Interim Management Statement of 12 August 2009, Grainger stated that it was in discussions with its lending banks regarding the planned refinancing of certain of its credit facilities.

Grainger now announces that it has successfully signed two new forward start credit facilities totalling £615 million which will provide extended liquidity for the Group at the time that certain of its existing facilities expire. 

These two new facilities comprise a £250 million committed term loan which will become available in June 2010 and a £365 million committed term loan available in June 2011.  They will, on those dates, be used to refinance existing revolving credit facilities of £400 million and £475 milliothat mature on those dates. As a separate matter, those facilities have now been reduced to £250 million and £445 million respectivelywhich the Group has been able to do by utilising excess short-term committed but undrawn facilities.  

Both the new forward start facilities will mature in December 2012.

The other facilities under Grainger's core borrowing agreement are a £228 million revolving credit facility maturing in December 2012 and £425 million of term loans maturing in June 2013. 

As a result of the above, the Group now has no core debt facilities maturing in its financial year to September 2010, with only £109 million maturing in its financial year to September 2011 and only £57 million in its financial year to September 2012.The Group continues to be highly cash generative. 

The method of calculation and limits under the Group's existing financial covenants remain unchanged by the negotiation of these new facilitiesThe Group's headroom as at 30 September was approximately £170 million. 

Following this successful refinancing, Grainger's average cost of debt (based on current LIBOR rates) is 5.5% (previously 4.6%). This would reduce to 5.2% should the Loan to Value ratio on the facilities fall below 60% (67% as at 30 June 2009).

Andrew CunninghamGrainger's Finance Director and Acting Chief Executive Officer, commented: 

"This refinancing results in Grainger having far greater certainty over its medium term financing. Under the old facilities there were aggregate debt repayments of about £90million to be made by June 2011. These are now reduced to about £110 million on 30 June 2011 and a minimal amount in the 18 months after that." 

For further information:

Grainger plc

Financial Dynamics

Andrew Cunningham/Nick On/Dave Butler 

Stephanie Highett/Dido Laurimore

Tel: +44 (0) 191 261 1819

+44 (0) 20 7795 4700

Tel: +44 (0) 20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCILFIRADIIVIA
Date   Source Headline
3rd Apr 20237:00 amRNSNotice of Results
13th Mar 202311:57 amRNSTotal Voting Rights
7th Mar 202312:46 pmRNSDirector/PDMR Shareholding
15th Feb 20231:35 pmRNSDirector/PDMR Shareholding
8th Feb 20234:16 pmRNSResult of AGM
8th Feb 20237:00 amRNSTrading Update
7th Feb 202312:12 pmRNSDirector/PDMR Shareholding
7th Feb 202312:08 pmRNSDirector/PDMR Shareholding
6th Feb 20233:14 pmRNSTotal Voting Rights
20th Jan 20235:12 pmRNSAGM Statement
12th Jan 202312:16 pmRNSTotal Voting Rights
10th Jan 20232:33 pmRNSDirector/PDMR Shareholding
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding
8th Dec 202210:36 amRNSDirectorate Change
7th Dec 20221:33 pmRNSDirector/PDMR Shareholding
6th Dec 202211:47 amRNSTotal Voting Rights
21st Nov 20221:12 pmRNSDividend Declaration
17th Nov 20227:00 amRNSFinal Results
14th Nov 20227:00 amRNSBoard Appointment
7th Nov 20222:47 pmRNSDirector/PDMR Shareholding
11th Oct 20223:00 pmRNSDirector/PDMR Shareholding
6th Oct 20223:12 pmRNSBlock listing Interim Review
29th Sep 20223:20 pmRNSDirector/PDMR Shareholding
29th Sep 202211:08 amRNSTotal Voting Rights
20th Sep 20221:23 pmRNSDirector Declaration
12th Sep 20227:00 amRNSTRADING UPDATE
12th Sep 20227:00 amRNSTrading Update
7th Sep 20222:31 pmRNSTotal Voting Rights
6th Sep 202212:29 pmRNSDirector/PDMR Shareholding
17th Aug 20222:49 pmRNSHolding(s) in Company
8th Aug 20222:34 pmRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSCapital Markets Event
4th Jul 20223:33 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSAcquisition
14th Jun 20222:22 pmRNSAdditional Listing
8th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSHolding(s) in Company
12th May 20227:00 amRNSHalf Year Financial Results
6th May 202210:48 amRNSDirector/PDMR Shareholding
21st Apr 20222:15 pmRNSHolding(s) in Company
7th Apr 202212:01 pmRNSDirector/PDMR Shareholding
1st Apr 202212:08 pmRNSBlock listing Interim Review
25th Mar 20227:00 amRNSNotice of Interim Results
7th Mar 202212:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202212:12 pmRNSTotal Voting Rights
3rd Mar 202212:08 pmRNSHolding(s) in Company
18th Feb 202211:07 amRNSDirector/PDMR Shareholding
9th Feb 20224:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.